Cerebellar cognitive affective syndrome associated with topiramate

被引:15
作者
Baillieux, Hanne [3 ]
Verslegers, Werner [4 ]
Paquier, Philippe [3 ,5 ,6 ]
De Deyn, Peter P. [1 ,2 ]
Marien, Peter [1 ,2 ,3 ]
机构
[1] Univ Antwerp, ZNA Middelheim, Dept Neurol, B-2020 Antwerp, Belgium
[2] Univ Antwerp, Inst Born Bunge, Lab Neurochem & Behav, B-2020 Antwerp, Belgium
[3] Vrije Univ Brussel, Dept Linguist, Brussels, Belgium
[4] ZNA Jan Palfijn, Dept Neurol, Antwerp, Belgium
[5] Univ Antwerp, Hop Univ Erasme ULB, Dept Neurol, Brussels, Belgium
[6] Univ Antwerp, Unit Neurosci, Brussels, Belgium
关键词
topiramate; cognitive affective syndrome; epilepsy; cognition; behavior; cerebellum; SPECT;
D O I
10.1016/j.clineuro.2008.01.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The cerebellar cognitive affective syndrome (CCAS) represents a spectrum of cerebellar-induced neurocognitive and affective disturbances. In this report a patient is described who developed CCAS under a treatment with standard daily dose of the anti-epileptic drug topiramate (TPM). Cognitive disturbances consisted of impaired visuo-spatial memory, concentration deficits and executive dysfunctions. Behavior and affect were characterized by marked mood-swings and several disinhibited symptoms. After a gradual discontinuation of treatment with topiramate, a complete remission of the cognitive and affective symptoms was observed within 6 weeks. Functional neuroimaging studies by means of SPECT were conducted 2 weeks and 8 months following TPM discontinuation. This case report seems to suggest that functional disruption of the cerebello-cerebral circuitry, leading to CCAS, can follow treatment with topiramate. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:496 / 499
页数:4
相关论文
共 15 条
[1]   Adult cerebellar mutism and cognitive-affective syndrome caused by cystic hemangioblastoma [J].
Akil, H ;
Statham, PFX ;
Götz, M ;
Bramley, P ;
Whittle, IR .
ACTA NEUROCHIRURGICA, 2006, 148 (05) :597-598
[2]   Neurobehavioral alterations in an adolescent following posterior fossa tumor resection [J].
Baillieux, Hanne ;
De Smet, Hyo Jung ;
Lesage, Geoffrey ;
Paquier, Philippe ;
De Deyn, Peter P. ;
Marien, Peter .
CEREBELLUM, 2006, 5 (04) :289-295
[3]   Reversible nonfluent aphasia and left frontal hypoperfusion during topiramate treatment [J].
Cappa, S. F. ;
Ortelli, P. ;
Garibotto, V. ;
Zamboni, M. .
EPILEPSY & BEHAVIOR, 2007, 10 (01) :192-194
[4]  
COLE M G, 1983, Journal of Clinical and Experimental Gerontology, V5, P219
[5]   Cognitive affective psychosis syndrome in a patient with sporadic olivopontocerebellar atrophy [J].
Duggal, HS .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 17 (02) :260-262
[6]   Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy [J].
Fritz, N ;
Glogau, S ;
Hoffmann, J ;
Rademacher, M ;
Elger, CE ;
Helmstaedter, C .
EPILEPSY & BEHAVIOR, 2005, 6 (03) :373-381
[7]   Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of Topiramate in epilepsy patients [J].
Kockelmann, E ;
Elger, CE ;
Hehnstaedter, C .
EPILEPSY RESEARCH, 2003, 54 (2-3) :171-178
[8]   The effects of adjunctive topiramate on cognitive function in patients with epilepsy [J].
Lee, S ;
Sziklas, V ;
Andermann, F ;
Farnham, S ;
Risse, G ;
Gustafson, M ;
Gates, J ;
Penovich, P ;
Al-Asmi, A ;
Dubeau, F ;
Jones-Gotman, M .
EPILEPSIA, 2003, 44 (03) :339-347
[9]   Normative data for the Boston Naming Test in native Dutch-speaking Belgian elderly [J].
Marien, P ;
Mampaey, E ;
Vervaet, A ;
Saerens, J ;
De Deyn, PP .
BRAIN AND LANGUAGE, 1998, 65 (03) :447-467
[10]   Cerebellar cognitive affective syndrome without global mental retardation in two relatives with Gillespie syndrome [J].
Marien, Peter ;
Brouns, Raf ;
Engelborghs, Sebastiaan ;
Wackenier, Peggy ;
Verhoeven, Jo ;
Ceulemans, Berten ;
De Deyn, Peter P. .
CORTEX, 2008, 44 (01) :54-67